Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L Galetta

Showing results (31-40 of 317) with videos related to

Pageof 32
Sort By:
Neurology|August 5, 2024
Editors' Note: Partially Reversible FLAIR Hyperintensity Along the Brainstem Surface in Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyAriane Lewis, Steven L Galetta
Neurology|February 5, 2025
Editors' Note: Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic CoreAravind Ganesh, Steven L Galetta
Neurology|March 6, 2025
Editors' Note: Domestic Violence and Abuse in People Living With Multiple SclerosisAravind Ganesh, Steven L Galetta
Neurology|February 13, 2025
Editors' Note: Implications of Large Language Models for Quality and Efficiency of Neurologic Care: Emerging Issues in NeurologyAriane Lewis, Steven L Galetta
Neurology|December 26, 2024
Editors' Note: Enduring Questions About Blood Pressure Reduction Parameters in ICH to Prevent Hemorrhage Expansion and Optimize Functional OutcomesAravind Ganesh, Steven L Galetta
Neurology|January 31, 2025
Editors' Note: A Preponderance of Evidence: A Call for a Randomized Trial in Posterior Circulation StrokeAriane Lewis, Steven L Galetta
Neurology|May 15, 2025
Editors' Note: Further Insights About the Benefits of Rapid Endovascular Thrombectomy for Acute Ischemic StrokeAravind Ganesh, Steven L Galetta
Neurology|January 30, 2026
Editors' Note: A Fond Farewell to AlteplaseAravind Ganesh, Steven L Galetta
CNS Drugs|March 3, 2005
US FDA-approved disease-modifying treatments for multiple sclerosis: review of adverse effect profilesSteven L Galetta, Clyde Markowitz
Neurology|December 3, 2024
Editors' Note: Teaching Video NeuroImage: Infantile Upbeat Nystagmus as an Isolated Presentation of <i>CACNA1F</i>-Related Retinal DystrophyAriane Lewis, Steven L Galetta
Pageof 32

Showing results (31-40 of 317) with videos related to

Sort By:
Pageof 32
Neurology|August 5, 2024
Editors' Note: Partially Reversible FLAIR Hyperintensity Along the Brainstem Surface in Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyAriane Lewis, Steven L Galetta
Neurology|February 5, 2025
Editors' Note: Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic CoreAravind Ganesh, Steven L Galetta
Neurology|March 6, 2025
Editors' Note: Domestic Violence and Abuse in People Living With Multiple SclerosisAravind Ganesh, Steven L Galetta
Neurology|February 13, 2025
Editors' Note: Implications of Large Language Models for Quality and Efficiency of Neurologic Care: Emerging Issues in NeurologyAriane Lewis, Steven L Galetta
Neurology|December 26, 2024
Editors' Note: Enduring Questions About Blood Pressure Reduction Parameters in ICH to Prevent Hemorrhage Expansion and Optimize Functional OutcomesAravind Ganesh, Steven L Galetta
Neurology|January 31, 2025
Editors' Note: A Preponderance of Evidence: A Call for a Randomized Trial in Posterior Circulation StrokeAriane Lewis, Steven L Galetta
Neurology|May 15, 2025
Editors' Note: Further Insights About the Benefits of Rapid Endovascular Thrombectomy for Acute Ischemic StrokeAravind Ganesh, Steven L Galetta
Neurology|January 30, 2026
Editors' Note: A Fond Farewell to AlteplaseAravind Ganesh, Steven L Galetta
CNS Drugs|March 3, 2005
US FDA-approved disease-modifying treatments for multiple sclerosis: review of adverse effect profilesSteven L Galetta, Clyde Markowitz
Neurology|December 3, 2024
Editors' Note: Teaching Video NeuroImage: Infantile Upbeat Nystagmus as an Isolated Presentation of <i>CACNA1F</i>-Related Retinal DystrophyAriane Lewis, Steven L Galetta
Pageof 32